FRANKLIN, Mass.—Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, has received FDA clearance of the all-in-one Anterion platform, designed to transform anterior segment diagnostics and streamline practice workflow. “Building upon our previous CE-marking, we are thrilled that the Anterion platform is now available to eyecare providers across the U.S.,” said Arianna Schoess Vargas, managing director of Heidelberg Engineering GmbH. “We believe this device complements our current portfolio of products and arms anterior segment focused practices with the comprehensive data needed to support diagnostic decisions that ultimately improve patient care.”

As an all-in-one upgradeable platform, Anterion combines biometry, IOL power calculation with corneal topography and tomography, anterior chamber metrics, and high-resolution imaging.

Mitchell W. Dul, OD, MS, principal investigator of the clinical trial, said, “We were impressed by the high-quality images and measurements of the anterior segment that Anterion offers. Its multi-faceted utility, high resolution, rapid image acquisition, and intuitive user interface will make this device an invaluable tool for clinical practice.”